ME

Jul 04, 2023

Trial Name: A Phase 1b Study of the OxPhos Inhibitor ME-344 Combined With Bevacizumab in Previously Treated Metastatic Colorectal Cancer

ClinicalTrials.gov Identifier: NCT05824559

Sponsor: MEI Pharma, Inc

Recruitment Contact: Sylwia Sobolewska, 347-522-0549, [email protected]

Completion Date: June 30, 2024

Trial Name:ClinicalTrials.gov Identifier:Sponsor:Recruitment Contact:Completion Date:

Send inquiry

Send